2014.1-8 FDA approved drug

2014.1-8 FDA approved drug

No.	Drug Name	Active Ingredient	Date	What It’s Used For
23.	Orbactiv	oritavancin	8/6/2014	To treat adults with skin  infections 9 G# G$ }7 @9 j/ m. h9 l7 X  Press Release
22.	Jardiance	empagliflozin	8/1/2104	To improve gylcemic control  in adults with type 2 diabetes 7 H. v8 O5 E1 J% v% l  Press Release
21.	Striverdi  Respimat	olodaterol	7/31/2014	To treat chronic obstructive  pulmonary disease 2 j# T% D5 f, s) K  Press Release
20. / [% ]( t+ g' y9 y- A/ N( X   6 G  F9 X' ^& S1 x; b	Zydelig	idelalisib	7/23/2014	To treat patients with trhee  types of blood cancers   Press Release
19.	Kerydin	tavaborole	7/7/2014	For the topical treatment of  onychomycosis of the toenails   (No Press Release)
18.	Beleodaq	belinostat	7/3/2014	To treat patients with  peripheral T-cell lymphoma (PTCL) % D" Y3 H0 V3 q+ M2 }  Press Release
17.	Sivextro (tablet)Sivextro  (injection)	tedizolid phosphate	6/20/2014	To treat adults with skin  infections 6 }1 ]; K) r0 `& v  Press Release
16.	Jublia      H: C$ h- w5 @% V0 Q; O	efinaconazole	6/6/2014	Treat mild to moderate  onychomycosis (fungal infection)    No Press Release
15.	Dalvance ) U+ _& O$ E$ S6 w/ a, ]) N2 Y  B6 ?6 O   " {7 {5 ]/ M" ~1 \% Y	dalbavancin	5/23/2014	To treat adults with skin  infections   Press Release
14.	Entyvio	vedolizumab	5/20/2014	To treat adult patients with  moderate to severe ulcerative colitis and adult patients with moderate to  severe Crohn‘s disease   Press Release
13.	Zontivity    5 A3 M: r0 T3 |+ h) z6 V9 i; Q8 Y	vorapaxar	5/8/2014	To reduce the risk of heart  attacks and stroke in high-risk patients   Press Release
12.	Zykadia	ceritinib	4/29/2014	To treat patients with a  certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC) % f4 u* [4 J# f' j8 x0 z( O  Press Release
11.	Sylvant	siltuximab	4/23/2014	To treat patients with multicentric  Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the  lymph nodes)   Press Release
10.	Cyramza	ramucirumab	4/21/2014	To treat patients with  advanced stomach cancer or gastroesophageal junction adenocarcinoma 3 m) |) I$ L2 ^" t; e  Press Release
9.	Tanzeum	albiglutide	4/15/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes - i4 x" l3 @4 \* |9 o% Z  Press Release
8.	Otezla	apremilast	3/21/2014	To treat adults with active  psoriatic arthritis (PsA)   Press Release
7.	Impavido	miltefosine	3/19/2014	To treat a tropical disease  called leishmaniasis $ e+ O, H6 R5 J9 E/ `/ R  Press Release
6.	Neuraceq	florbetaben F 18 injection	3/19/2014	For Positron  EmissionTomography (PET) imaging of the brain
5.	Myalept	metreleptin for injection	2/24/2014	To treat the complications  of leptin deficiency 1 I) ?5 f( B7 y& R7 G  y2 J3 Z8 t  Press Release
4.	Northera	droxidopa	2/18/2014	To treat neurogenic  orthostatic hypotension (NOH) % A6 g7 M# n& q1 S+ z3 Z  Press Release
3.	Vimizim	elosulfase alfa	2/14/2014	Treatment for Mucopolysaccharidosis Type IVA  (Morquio A syndrome) & Q  t1 d  f5 A; {  P$ ~  Press Release
2.	Hetlioz	tasimelteon	1/31/2014	To treat non-24- hour sleep-wake disorder (“non-24”)  in totally blind individuals. Non-24 is a chronic circadian rhythm (body  clock) disorder in the blind that causes problems with the timing of sleep.Press Release
1.	Farxiga	dapaglifozin	1/8/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes   s  G3 l/ n. T( p5 L2 ]7 J  Press Release

+ D, Z0 h# v3 ~) _0 E  G

感谢楼主分享，楼主好强大